The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...
D-Wave Quantum stock gains attention amid institutional activity and quantum computing developments. Explore key drivers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results